SGH
SANA icon

Sivik Global Healthcare’s Sana Biotechnology SANA Stock Holding History

Sivik Global Healthcare’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-63,446
Closed -$1.25M – 52
2021
Q2 		$1.25M Buy
+63,446
New +$1.44M 0.24% 48

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sivik Global Healthcare's SANA Position: Q3 2021 in Review

Sivik Global Healthcare sold out of Sana Biotechnology (SANA) in Q3 2021, closing a stake of 63,446 shares — an estimated $1.25M sold.

Sivik Global Healthcare first reported a position in SANA in Q2 2021 and held it in 1 quarter. The position peaked at $1.25M in Q2 2021. 88 funds tracked by Wall St. Rank hold SANA as of Q3 2021.

  • Sivik Global Healthcare reported no remaining Sana Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Sivik Global Healthcare sold 63,446 Sana Biotechnology shares in Q3 2021, an estimated $1.25M.
  • Sivik Global Healthcare first reported a position in Sana Biotechnology in Q2 2021 and held it in 1 quarter.
  • Sivik Global Healthcare's Sana Biotechnology position peaked at $1.25M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2021.

Based on Sivik Global Healthcare's 13F filing for Q3 2021, filed 12 Nov 2021.